Do analysts prefer UK or NOTV?

Inotiv has a consensus target price of $1.50, indicating a potential upside of 13,413.51%. Given Inotiv's stronger consensus rating and higher possible upside, analysts clearly believe Inotiv is more favorable than Ucommune International. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ucommune International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Inotiv 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has preferable valuation and earnings, UK or NOTV?

Ucommune International has higher earnings, but lower revenue than Inotiv. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ucommune International $3.73M 0.38 -$5.41M N/A N/A Inotiv $507.36M 0.00 -$68.62M -$2.53 N/A

Do analysts rate HAO or NOTV?

Inotiv has a consensus price target of $1.50, suggesting a potential upside of 13,413.51%. Given Inotiv's stronger consensus rating and higher probable upside, analysts plainly believe Inotiv is more favorable than Haoxi Health Technology. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Haoxi Health Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Inotiv 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has preferable earnings & valuation, HAO or NOTV?

Haoxi Health Technology has higher earnings, but lower revenue than Inotiv. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Haoxi Health Technology $32.80M 0.04 $3.88M N/A N/A Inotiv $507.36M 0.00 -$68.62M -$2.53 N/A

Do analysts prefer OCG or NOTV?

Inotiv has a consensus target price of $1.50, indicating a potential upside of 13,413.51%. Given Inotiv's stronger consensus rating and higher probable upside, analysts clearly believe Inotiv is more favorable than Oriental Culture. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Oriental Culture 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Inotiv 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has preferable earnings & valuation, OCG or NOTV?

Oriental Culture has higher earnings, but lower revenue than Inotiv. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Oriental Culture $1.89M 0.52 -$3.86M N/A N/A Inotiv $507.36M 0.00 -$68.62M -$2.53 N/A

Which has better earnings and valuation, TNMG or NOTV?

TNL Mediagene has higher earnings, but lower revenue than Inotiv. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio TNL Mediagene $45.02M 0.03 -$44.55M N/A N/A Inotiv $507.36M 0.00 -$68.62M -$2.53 N/A

Do analysts prefer NOTV or VCIG?

Inotiv currently has a consensus price target of $1.50, suggesting a potential upside of 13,413.51%. Given Inotiv's stronger consensus rating and higher possible upside, equities analysts plainly believe Inotiv is more favorable than VCI Global. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inotiv 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 VCI Global 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger valuation and earnings, NOTV or VCIG?

VCI Global has lower revenue, but higher earnings than Inotiv. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Inotiv $507.36M 0.00 -$68.62M -$2.53 N/A VCI Global $26.09M 0.03 -$30.26M N/A N/A

Is NOTV or VCIG more profitable?

VCI Global has a net margin of 0.00% compared to Inotiv's net margin of -17.14%. VCI Global's return on equity of 0.00% beat Inotiv's return on equity. Company Net Margins Return on Equity Return on Assets Inotiv -17.14% -56.77% -8.91% VCI Global N/A N/A N/A

Inotiv (NOTV) Competitors

$0.01 0.00 (-26.00%)

As of 07/17/2026

Compare

NOTV vs. UK, HAO, OCG, TNMG, and VCIG

Should you buy Inotiv stock or one of its competitors? MarketBeat compares Inotiv with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Inotiv include Ucommune International (UK), Haoxi Health Technology (HAO), Oriental Culture (OCG), TNL Mediagene (TNMG), and VCI Global (VCIG).

How does Inotiv compare to Ucommune International?

Ucommune International (NASDAQ:UK) and Inotiv (NASDAQ:NOTV) are related small-cap companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, risk, earnings, valuation, institutional ownership and media sentiment.

Ucommune International has a beta of 0.86, suggesting that its stock price is 14% less volatile than the broader market. Comparatively, Inotiv has a beta of 3.77, suggesting that its stock price is 277% more volatile than the broader market.

In the previous week, Ucommune International's average media sentiment score of 0.00 equaled Inotiv'saverage media sentiment score.

Company	Overall Sentiment
Ucommune International	Neutral
Inotiv	Neutral

Ucommune International has a net margin of 0.00% compared to Inotiv's net margin of -17.14%. Ucommune International's return on equity of 0.00% beat Inotiv's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ucommune International	N/A	N/A	N/A
Inotiv	-17.14%	-56.77%	-8.91%

Ucommune International has higher earnings, but lower revenue than Inotiv.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ucommune International	$3.73M	0.38	-$5.41M	N/A	N/A
Inotiv	$507.36M	0.00	-$68.62M	-$2.53	N/A

Inotiv has a consensus target price of $1.50, indicating a potential upside of 13,413.51%. Given Inotiv's stronger consensus rating and higher possible upside, analysts clearly believe Inotiv is more favorable than Ucommune International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ucommune International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Inotiv	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

36.9% of Ucommune International shares are held by institutional investors. Comparatively, 18.2% of Inotiv shares are held by institutional investors. 14.2% of Ucommune International shares are held by insiders. Comparatively, 7.8% of Inotiv shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Ucommune International beats Inotiv on 7 of the 12 factors compared between the two stocks.

How does Inotiv compare to Haoxi Health Technology?

Haoxi Health Technology (NASDAQ:HAO) and Inotiv (NASDAQ:NOTV) are related small-cap companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, dividends, analyst recommendations, media sentiment, profitability, risk, institutional ownership and valuation.

Inotiv has a consensus price target of $1.50, suggesting a potential upside of 13,413.51%. Given Inotiv's stronger consensus rating and higher probable upside, analysts plainly believe Inotiv is more favorable than Haoxi Health Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Haoxi Health Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Inotiv	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Haoxi Health Technology's average media sentiment score of 0.00 equaled Inotiv'saverage media sentiment score.

Company	Overall Sentiment
Haoxi Health Technology	Neutral
Inotiv	Neutral

Haoxi Health Technology has higher earnings, but lower revenue than Inotiv.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Haoxi Health Technology	$32.80M	0.04	$3.88M	N/A	N/A
Inotiv	$507.36M	0.00	-$68.62M	-$2.53	N/A

Haoxi Health Technology has a net margin of 0.00% compared to Inotiv's net margin of -17.14%. Haoxi Health Technology's return on equity of 0.00% beat Inotiv's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Haoxi Health Technology	N/A	N/A	N/A
Inotiv	-17.14%	-56.77%	-8.91%

Haoxi Health Technology has a beta of -1.13, suggesting that its share price is 213% less volatile than the broader market. Comparatively, Inotiv has a beta of 3.77, suggesting that its share price is 277% more volatile than the broader market.

18.2% of Inotiv shares are owned by institutional investors. 7.8% of Inotiv shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Inotiv beats Haoxi Health Technology on 7 of the 12 factors compared between the two stocks.

How does Inotiv compare to Oriental Culture?

Oriental Culture (NASDAQ:OCG) and Inotiv (NASDAQ:NOTV) are related small-cap companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, profitability, dividends, valuation, analyst recommendations, earnings and media sentiment.

Oriental Culture has a beta of 0.42, meaning that its share price is 58% less volatile than the broader market. Comparatively, Inotiv has a beta of 3.77, meaning that its share price is 277% more volatile than the broader market.

In the previous week, Oriental Culture's average media sentiment score of 0.00 equaled Inotiv'saverage media sentiment score.

Company	Overall Sentiment
Oriental Culture	Neutral
Inotiv	Neutral

Oriental Culture has a net margin of 0.00% compared to Inotiv's net margin of -17.14%. Oriental Culture's return on equity of 0.00% beat Inotiv's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Oriental Culture	N/A	N/A	N/A
Inotiv	-17.14%	-56.77%	-8.91%

1.6% of Oriental Culture shares are owned by institutional investors. Comparatively, 18.2% of Inotiv shares are owned by institutional investors. 23.9% of Oriental Culture shares are owned by insiders. Comparatively, 7.8% of Inotiv shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Inotiv has a consensus target price of $1.50, indicating a potential upside of 13,413.51%. Given Inotiv's stronger consensus rating and higher probable upside, analysts clearly believe Inotiv is more favorable than Oriental Culture.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Oriental Culture	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Inotiv	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Oriental Culture has higher earnings, but lower revenue than Inotiv.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Oriental Culture	$1.89M	0.52	-$3.86M	N/A	N/A
Inotiv	$507.36M	0.00	-$68.62M	-$2.53	N/A

Summary

Oriental Culture and Inotiv tied by winning 6 of the 12 factors compared between the two stocks.

How does Inotiv compare to TNL Mediagene?

TNL Mediagene (NASDAQ:TNMG) and Inotiv (NASDAQ:NOTV) are related small-cap companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, dividends, earnings, media sentiment and risk.

In the previous week, TNL Mediagene had 6 more articles in the media than Inotiv. MarketBeat recorded 6 mentions for TNL Mediagene and 0 mentions for Inotiv. TNL Mediagene's average media sentiment score of 0.55 beat Inotiv's score of 0.00 indicating that TNL Mediagene is being referred to more favorably in the media.

Company	Overall Sentiment
TNL Mediagene	Positive
Inotiv	Neutral

TNL Mediagene has a beta of 0.81, meaning that its share price is 19% less volatile than the broader market. Comparatively, Inotiv has a beta of 3.77, meaning that its share price is 277% more volatile than the broader market.

TNL Mediagene has a net margin of 0.00% compared to Inotiv's net margin of -17.14%. TNL Mediagene's return on equity of 0.00% beat Inotiv's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TNL Mediagene	N/A	N/A	N/A
Inotiv	-17.14%	-56.77%	-8.91%

TNL Mediagene has higher earnings, but lower revenue than Inotiv.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TNL Mediagene	$45.02M	0.03	-$44.55M	N/A	N/A
Inotiv	$507.36M	0.00	-$68.62M	-$2.53	N/A

18.2% of Inotiv shares are owned by institutional investors. 41.0% of TNL Mediagene shares are owned by company insiders. Comparatively, 7.8% of Inotiv shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

TNL Mediagene currently has a consensus target price of $14.00, indicating a potential upside of 2,843.03%. Inotiv has a consensus target price of $1.50, indicating a potential upside of 13,413.51%. Given Inotiv's higher possible upside, analysts clearly believe Inotiv is more favorable than TNL Mediagene.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TNL Mediagene	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Inotiv	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

TNL Mediagene beats Inotiv on 8 of the 12 factors compared between the two stocks.

How does Inotiv compare to VCI Global?

Inotiv (NASDAQ:NOTV) and VCI Global (NASDAQ:VCIG) are related small-cap companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, dividends, risk, institutional ownership, analyst recommendations, media sentiment, earnings and profitability.

VCI Global has lower revenue, but higher earnings than Inotiv.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inotiv	$507.36M	0.00	-$68.62M	-$2.53	N/A
VCI Global	$26.09M	0.03	-$30.26M	N/A	N/A

Inotiv currently has a consensus price target of $1.50, suggesting a potential upside of 13,413.51%. Given Inotiv's stronger consensus rating and higher possible upside, equities analysts plainly believe Inotiv is more favorable than VCI Global.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inotiv	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
VCI Global	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, VCI Global had 2 more articles in the media than Inotiv. MarketBeat recorded 2 mentions for VCI Global and 0 mentions for Inotiv. Inotiv's average media sentiment score of 0.00 equaled VCI Global'saverage media sentiment score.

Company	Overall Sentiment
Inotiv	Neutral
VCI Global	Neutral

Inotiv has a beta of 3.77, suggesting that its stock price is 277% more volatile than the broader market. Comparatively, VCI Global has a beta of 7.87, suggesting that its stock price is 687% more volatile than the broader market.

18.2% of Inotiv shares are held by institutional investors. Comparatively, 0.2% of VCI Global shares are held by institutional investors. 7.8% of Inotiv shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

VCI Global has a net margin of 0.00% compared to Inotiv's net margin of -17.14%. VCI Global's return on equity of 0.00% beat Inotiv's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Inotiv	-17.14%	-56.77%	-8.91%
VCI Global	N/A	N/A	N/A

Summary

VCI Global beats Inotiv on 7 of the 13 factors compared between the two stocks.

Get Inotiv News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NOTV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NOTV vs. The Competition

Export

Metric	Inotiv	Pharmaceuticals Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$387K	$11.49B	$6.83B	$12.76B
Dividend Yield	N/A	2.73%	2.59%	10.01%
P/E Ratio	0.00	791.61	279.15	25.53
Price / Sales	0.00	733.42	595.58	92.32
Price / Cash	0.82	71.54	72.11	49.39
Price / Book	0.00	10.84	13.06	6.11
Net Income	-$68.62M	$2.81B	$3.48B	$347.58M
7 Day Performance	N/A	2.65%	3.40%	4.91%
1 Month Performance	N/A	-3.16%	-2.79%	-2.06%
1 Year Performance	N/A	190.96%	73.10%	21.03%

Inotiv Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NOTV Inotiv	1.3123 of 5 stars	$0.01 -26.0%	$1.50 +13,413.5%	-99.5%	$387K	$507.36M	N/A	2,046	Gap Down
UK Ucommune International	0.8845 of 5 stars	$1.95 -5.8%	N/A	-79.2%	$1.38M	$3.73M	N/A	510	Positive News
HAO Haoxi Health Technology	0.2387 of 5 stars	$0.16 -5.8%	N/A	-99.9%	$1.26M	$32.80M	N/A	29	Gap Down
OCG Oriental Culture	0.1737 of 5 stars	$1.78 +3.5%	N/A	N/A	$1M	$1.89M	N/A	50	Gap Down High Trading Volume
TNMG TNL Mediagene	2.5312 of 5 stars	$0.39 +4.4%	$14.00 +3,499.9%	-94.8%	$950K	$45.02M	N/A	N/A	News Coverage Gap Down High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:NOTV) was last updated on 8/5/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Inotiv (NOTV) Competitors

NOTV vs. UK, HAO, OCG, TNMG, and VCIG

How does Inotiv compare to Ucommune International?

Summary

How does Inotiv compare to Haoxi Health Technology?

Summary

How does Inotiv compare to Oriental Culture?

Summary

How does Inotiv compare to TNL Mediagene?

Summary

How does Inotiv compare to VCI Global?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NOTV vs. The Competition

Inotiv Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Inotiv (NOTV) Competitors

NOTV vs. UK, HAO, OCG, TNMG, and VCIG

How does Inotiv compare to Ucommune International?

Which has more volatility & risk, UK or NOTV?

Does the media favor UK or NOTV?

Is UK or NOTV more profitable?

Which has preferable valuation and earnings, UK or NOTV?

Do analysts prefer UK or NOTV?

Do institutionals & insiders have more ownership in UK or NOTV?

Summary

How does Inotiv compare to Haoxi Health Technology?

Do analysts rate HAO or NOTV?

Does the media prefer HAO or NOTV?

Which has preferable earnings & valuation, HAO or NOTV?

Is HAO or NOTV more profitable?

Which has more volatility and risk, HAO or NOTV?

Do insiders & institutionals hold more shares of HAO or NOTV?

Summary

How does Inotiv compare to Oriental Culture?

Which has more risk and volatility, OCG or NOTV?

Does the media prefer OCG or NOTV?

Is OCG or NOTV more profitable?

Do institutionals and insiders believe in OCG or NOTV?

Do analysts prefer OCG or NOTV?

Which has preferable earnings & valuation, OCG or NOTV?

Summary

How does Inotiv compare to TNL Mediagene?

Does the media prefer TNMG or NOTV?

Which has more volatility & risk, TNMG or NOTV?

Is TNMG or NOTV more profitable?

Which has better earnings and valuation, TNMG or NOTV?

Do insiders & institutionals believe in TNMG or NOTV?

Do analysts prefer TNMG or NOTV?

Summary

How does Inotiv compare to VCI Global?

Which has stronger valuation and earnings, NOTV or VCIG?

Do analysts prefer NOTV or VCIG?

Does the media refer more to NOTV or VCIG?

Which has more volatility and risk, NOTV or VCIG?

Do insiders and institutionals believe in NOTV or VCIG?

Is NOTV or VCIG more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NOTV vs. The Competition

Inotiv Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools